Massive hyperlipemia during estrogen therapy.
D000085:Acetates / Q000009:adverse effects; D000328:Adult; D002784:Cholesterol / Q000097:blood; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004967:Estrogens / Q000009:adverse effects* / Q000494:pharmacology; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced* / Q000150:complications; D006973:Hypertension / Q000150:complications; D008593:Menopause / Q000187:drug effects; D008656:Mestranol / Q000009:adverse effects; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects; D014280:Triglycerides / Q000097:blood
D000085:Acetates; D003276:Contraceptives, Oral; D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D014280:Triglycerides; D004997:Ethinyl Estradiol; D002784:Cholesterol; D008656:Mestranol; D009640:Norethindrone